HOME >> MEDICINE >> NEWS
Aspirin reduces cardiovascular risks in men and women -- but differently

Aspirin can significantly reduce the risk of cardiovascular events -- a combined endpoint including stroke, heart attack and death due to cardiovascular disease -- in both men and women, according to a new meta-analysis of more than 95,000 patients by a Duke University Medical Center cardiologist.

However, the researchers found, the major reasons for the risk reduction differed between the sexes. For men, aspirin lowered the risk of a heart attack, while in women, aspirin reduced the risk of a stroke.

The use of aspirin, however, also carries an increased risk of bleeding among both sexes, the study found. The results of the new analysis lead the researchers to recommend that all patients and physicians should discuss the benefits and drawbacks of regularly taking aspirin as a preventative measure against cardiovascular events.

"Aspirin is a drug that has been used for many years it is well-understood, effective, inexpensive and widely available," said Duke cardiology fellow Jeffrey Berger, M.D, first author of a paper published Jan. 18, 2006, in the Journal of the American Medical Association. He performed much of the research while at Beth Israel Medical Center, New York, under senior author cardiologist David Brown, M.D.

"This is good news because many of the past studies of the effect of aspirin in preventing cardiovascular events looked only at men, so physicians were reluctant to prescribe aspirin for women because there was little data," Berger continued. "But now, the combined data of recent trials involving women demonstrates that women can benefit just as much from aspirin therapy as men."

Berger emphasized that more healthy men and women who can tolerate aspirin should be taking the medication for the prevention of cardiovascular disease. It is estimated that fewer than five percent of the population suffers from the known gastrointestinal side effects of aspirin or are allergic to it, meaning that many more seriou
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
17-Jan-2006


Page: 1 2 3

Related medicine news :

1. Aspirin use during pregnancy could reduce risk of pre-eclampsia
2. Aspirin reduces esophageal-cancer risk in people with most-aggressive form of Barretts esophagus
3. Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding
4. Aspirin and other NSAIDs may not reduce the risk of colorectal cancer in long-term smokers
5. Aspirin + dipyridamole better than aspirin alone to prevent circulatory problems after minor stroke
6. Aspirin shows promise in combating a common, antibiotic-induced hearing loss
7. Aspirin to prevent heart disease is beneficial in a wider range of men
8. Aspirin therapy may be safe for some survivors of brain hemorrhage
9. Aspirin reduces the risk of cardiovascular events, though effects differ between men and women
10. Aspirin may help the heart, but one in ten patients will also develop an ulcer, new research shows
11. Aspirin can cut death rates in postmenopausal women with cardiovascular disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... ... management solution focused on delivering end-to-end sleep health care at scale, indicates ... literature shows that adherence rates for positive airway pressure (PAP) therapy, the most ...
(Date:7/24/2017)... BEACH, Calif. (PRWEB) , ... July 24, 2017 , ... ... ranging from food addiction to sexual abuse, and how she has overcome them. “Forbidden ... traumatic instances in her life and how she has risen above. , In “Memories,” ...
(Date:7/24/2017)... PA (PRWEB) , ... July 24, 2017 , ... ... 2030, today CURE announced that they have enrolled over 100,000 children in their ... afflicted children born every year in areas where treatment is limited or non-existent. ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical ... MSceppa Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , ... Increased FDA scrutiny and growing demands to track and report adverse events place ...
(Date:7/24/2017)... ... July 24, 2017 , ... On July ... was set up, and the awarding ceremony was held successfully in Beijing. The ... of the army's health system, and national Chinese medicine experts also attended the ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/10/2017)... 2017 Locus Biosciences Inc. today announced the ... development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the round ... Internet services provider, and joined by the North Carolina ... product programs targeting antibiotic resistant infections and other microbiome-related ... Dr. Rodolphe Barrangou and Dr. Charles ...
(Date:7/5/2017)... , July 5, 2017 Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... it has received approval from the Israel Securities Authority to ... (TASE). Oramed common stock will commence trading on the TASE ... the current market capitalization of the Company, it is expected ...
Breaking Medicine Technology:
Cached News: